Cargando…
Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls
BACKGROUND: Pancreatic cancer (PC) is an aggressive disease with an urgent need for biomarkers. Hallmarks of PC include increased collagen deposition (desmoplasia) and increased matrix metalloproteinase (MMP) activity. The aim of this study was to investigate whether protein fingerprints of specific...
Autores principales: | Willumsen, Nicholas, Bager, Cecilie L, Leeming, Diana J, Smith, Victoria, Karsdal, Morten A, Dornan, David, Bay-Jensen, Anne-Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222497/ https://www.ncbi.nlm.nih.gov/pubmed/24261855 http://dx.doi.org/10.1186/1471-2407-13-554 |
Ejemplares similares
-
Nidogen-1 Degraded by Cathepsin S can be Quantified in Serum and is Associated with Non–Small Cell Lung Cancer
por: Willumsen, Nicholas, et al.
Publicado: (2017) -
Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer
por: Willumsen, Nicholas, et al.
Publicado: (2014) -
Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa
por: Wang, Song, et al.
Publicado: (2021) -
Matrix Metalloprotease Generated Fragments of Type VI Collagen Have Serum Biomarker Potential in Cancer – A Proof of Concept Study
por: Willumsen, Nicholas, et al.
Publicado: (2019) -
Excessive matrix metalloprotease-mediated degradation of interstitial tissue (type I collagen) independently predicts short-term survival in an observational study of postmenopausal women diagnosed with cancer
por: Willumsen, Nicholas, et al.
Publicado: (2017)